Proof of the high quality of the Olainfarm products is cooperation with such global and regionally acknowledged companies as Novartis, Dr. Reddy’ s, Glenmark Generics, Sigma AU, Almirall Ranke, UQUIFA, MIAT, Actavis, Teva, Egis, PHF and many others. Since 2011 Olainfarm supplies anti-tuberculosis medication to the World Health Organisation.
The company owns the controlling stake in the leading Latvian food supplement company Silvanols, has its own chain of pharmacies Latvijas aptieka in Latvia, owns producer of elastic medical products Tonus Elast, producer of natural herbal medicines and food supplements NPK Biotest (Belarus), medical companies Klīnika DiaMed and Olainmed, eco-cosmetics company Kiwi Cosmetics.
Representative offices in Russia, Ukraine, Belarus, Tajikistan, Albania, Armenia, Kazakhstan, Kosovo, Mongolia, Georgia and Uzbekistan, subsidiaries in Latvia, Belarus, Russia, Lithuania, Estonia, the Czech Republic, Turkey, Azerbaijan and Kyrgyzstan, and contracted agents in the USA, India, Turkmenistan, Moldova, Sweden and Southeast Asia.
Consolidated sales in 2018 – 124,3 million euros, profit – 10,7 million euros.
Olainfarm Group exports to more than 60 countries worldwide, export share is near 75%. Olainfarm main export markets are Russia, Ukraine, Belarus, The Netherlands, Kazakhstan, Uzbekistan and Germany. Farthest export market – Australia.
Highly professional, committed and devoted team of over 1000.
Site area of 480 000 square meter with easy access to highway and airport.
Olainfarm shares are listed at NASDAQ OMX Riga Official List.